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ROLE OF EXPRESSION OF P63 AND  
CALPONIN IN PROSTATIC LESIONS 
 
ABSTRACT 
Introduction:  
Histopathological diagnosis of benign prostatic hyperplasia and prostatic carcinoma 
may pose problems due to presence of mimickers. p63 is confined to basal cells 
/myoepithelial cells of prostate. In prostate cancer there is presence of reactive stroma 
instead of normal fibromuscular stroma. Calponin is expressed in cytoplasm of 
smooth muscle cells of normal stroma and its decreased or loss of expression is 
believed to play a role in tumorigenesis including prostatic carcinoma. 
Objectives:  
This study is done to assess the diagnostic utility of p63 staining in prostatic lesions, 
to assess the expression of calponin in benign and malignant prostatic lesions and to 
determine the relationship between the immunostaining and histologic grade of 
prostatic carcinoma 
Materials and methods: 
Biopsy specimen from a total of 60 cases which included 30 cases of BPH, 2 cases of 
Prostatic intraepithelial neoplasia and 28 cases of prostatic carcinoma were obtained 
by TURP and needle biopsies. For each case biochemical parameters were obtained. 
Immunohistochemical analysis was performed on routinely processed, formalin fixed, 
paraffin embedded tissue. Tissue sections were cut at 4µ thickness and mounted on 
gelatin coated slides. Immunohistochemical staining was done for both p63 and 
calponin. Expression of each of markers was graded accordingly. 
Results: 
 p63: Among 30 BPH, 27  cases(90%)  showed positivity and 3 cases(10%) showed 
negativity. All 2 cases of Prostatic intraepithelial neoplasia showed focal positivity. 
All 28 case of prostatic adenocarcinoma showed negative basal staining (100%) out of 
which 14 cases (50%) showed aberrant cytoplasmic staining. Sensitivity of p63 was 
90% and specificity was 100%. 
Calponin: Among 30 cases of BPH 25 cases(83.3%) showed score 3 staining, 4 cases 
(13.3%) showed moderate score 2 staining and 1 case (3.3%) showed low intensity of 
staining. 28 cases showed high staining index. Both cases of Prostatic intraepithelial 
neoplasia show moderate staining. Out of 28 prostatic carcinoma 19 cases (67.8%) 
showed low staining/score1. 2 cases (7.1%) showed negative staining and 7 cases 
(24.9%) showed moderate to strong staining. 23 cases of prostatic carcinoma showed 
low to moderate staining index. 
The expression of both these markers were statistically significant (p<0.05) 
Conclusion: 
p63 and calponin are highly expressed in benign and preneoplastic lesions. p63  
is a valuable tool with high specificity in differentiating BPH from prostatic 
carcinoma. The decreased or absent stromal staining of calponin which indicates a 
reactive stroma in malignancy can be used alone or in conjunction with p63 for 
confirmation of diagnosis of prostatic carcinoma.               
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